Skip to main content
Clinical Trials/CTRI/2024/08/071959
CTRI/2024/08/071959
Recruiting
Phase 2

Clinical Validation of Dozee’s Contactless Vital Sign Measurements - NI

Turtle Shell Technologies Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Turtle Shell Technologies Pvt Ltd
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Turtle Shell Technologies Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Consenting adults 18 to 99 years ICU patients
  • They or legal representative are able and willing to provide written informed consent or have a legally authorized representative willing to provide written informed consent
  • For NcBP Patients already on radial ABP line or whose BP is measured using cuff BP
  • For RR Patients on continuous capnography monitoring
  • For HR patients on continuous ECG monitoring
  • Patients who have been screened for HR RR and or NcBP can be included for the data collection of SpO2 temperature and NiBP data.

Exclusion Criteria

  • Currently pregnant
  • Exhibit injuries deformities or other abnormalities that in the opinion of the investigator, may prevent proper placement of accessories
  • Level of agitation or non\-compliance too high to enroll
  • Needs the use of equipments whose operation can interfere with Dozee signal
  • A significant medical condition in the judgment of the investigator which may compromise the study testing procedures

Outcomes

Primary Outcomes

Not specified

Similar Trials